Kailera Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Kailera Therapeutics stock have an average target of 39, with a low estimate of 30 and a high estimate of 48. The average target predicts an increase of 87.23% from the current stock price of 20.83.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$39	$48	$48
Change	+44.02%	+87.23%	+130.44%	+130.44%

* Price targets were last updated on May 28, 2026.

Analyst Ratings

The average analyst rating for Kailera Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	May '26	Jun '26
Strong Buy	5	5
Buy	1	1
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Roger Song Jefferies	Jefferies	Buy Maintains $48	Buy	Maintains	$48	+130.44%	May 28, 2026
Andy Hsieh William Blair	William Blair	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 27, 2026
Yaron Werber TD Cowen	TD Cowen	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 27, 2026
Umer Raffat Evercore ISI	Evercore ISI	Buy Initiates n/a	Buy	Initiates	n/a	n/a	May 12, 2026
Hardik Parikh J.P. Morgan	J.P. Morgan	Buy Initiates $30	Buy	Initiates	$30	+44.02%	May 12, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-4.29

EPS Next Year

-3.73

from -4.29

Fiscal Year	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
EPS	-	-7,819.98	-3.67	-3.71	-3.30
EPS Growth	-	-	-	-	-
Forward PE	-	-	-	-	-
No. Analysts	-	-	6	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-	-
Avg	-4.29	-3.73
Low	-	-

EPS Growth

EPS Growth	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.